Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 15, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 15, 2023Recruiting
Condition(s):HIV InfectionsLast Updated:May 30, 2023Recruiting
Condition(s):Objective Response RateLast Updated:June 9, 2021Recruiting
Condition(s):DLBCL – Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Follicular Lymphoma; Mediastinal Large B-cell Lymphoma; Indolent B-Cell Non-Hodgkin Lymphoma; Relapsed Non-Hodgkin Lymphoma; Refractory Non-Hodgkin LymphomaLast Updated:October 2, 2023Recruiting
Condition(s):T-cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepato-splenic T-cell Lymphoma; Adult T-cell Leukemia/Lymphoma; Enteropathy Associated T-cell Lymphoma; NK T-cell LymphomaLast Updated:February 20, 2024Recruiting
Condition(s):T Lymphoblastic Leukemia/LymphomaLast Updated:August 15, 2023Recruiting
Condition(s):Multiple Myeloma; Relapse Multiple MyelomaLast Updated:January 31, 2024Recruiting
Condition(s):Early-stage; Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeLast Updated:December 8, 2021Recruiting
Condition(s):Systemic Lupus Erythematosus; CAR-T Cell TherapyLast Updated:January 25, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:October 25, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.